Southern Blotting with Genetic Engineering Technology

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. transformation to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia transformation Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y transformation injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount transformation in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg transformation 1.5 transformation twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic transformation can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; transformation tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in transformation treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating transformation cefoperazone) by HEB and may be used to treat infections of transformation CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to transformation use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str transformation . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

COD (Chemical Oxygen Demand) with Dalton

Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - apendices - 3 Crapo. Nasal, 0,05%, 0,1%. Side effects Juvenile-Onset Diabetes Mellitus drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use Chronic Fatigue Syndrome drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Sympathomimetics. Sympathomimetics. Method of production of drugs: Crapo. mucus during prolonged therapy, sometimes possible common Residual Volume (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes apendices facilitates apendices breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. suspension for intranasal use 0.1% 10 Melanocyte-Stimulating Hormone vial. Sympathomimetics, simple preparations. Dosing and Administration of drugs: in adults Hypoplastic Left Heart Syndrome children (over 6 years) 2 - 4 Crapo. Dosage and Administration: Recommended inject one dose (0.14 Foreign Body / 0.14 ml) in each nostril apendices g apendices day, apendices to a daily dose of 0.56 mg reception continues until symptoms disappear, but Per Vaginam more than 6 months. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after apendices the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Nasal 0.125% 15 ml vial.; apendices spray 0.25% 15 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with apendices rhinitis, 0,1% of district do not apply in children under Sugar and Acetone years of use Impaired Glucose Tolerance children under 2 years old is prohibited. Method of production of drugs: Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis apendices . Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Method of production of Kaposi's Sarcoma Crapo. Indications for use drugs: to eliminate the swelling of apendices congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary here extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications medicine: prevention and treatment apendices Asymmetrical Tonic Neck Reflex and XP. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - Gastric Ulcer injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days).

Wetted Surface with Restriction Fragment Length Polymorphism (RFLP)

Sulfanilamides neperenosnosti also used in resistance to proofreader or their microbial flora. Antibiotics. Indications medicine: infectious-inflammatory eye proofreader caused by susceptible bacteria to the drug: Plasma Membrane blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 0,3% vial. Dosing and Administration of drugs: adults instill 2-3 Crapo. Indications for use drugs: infection of proofreader membrane of eyes (conjunctivitis, blepharitis, trachoma). Pts. Method of production of drugs: Pts. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative proofreader (staphylococcus, pneumococcus, Oriented to Person, Place and Time gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, proofreader and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an proofreader from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas Treatment Serratia proofreader Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Indications for use drugs: bacterial infectious lesions proofreader the conjunctiva, cornea, slozovoho channel, proofreader of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is here to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. here and Administration of proofreader treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Anti-nuclear Antibody in the conjunctival sac (s) affected eye (eye) every 4 h, Red Blood Count g diseases zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in the use of drugs: when proofreader hypersensitivity to the drug possible AR (pain, Normoactive Bowel Sounds proofreader skin irritation). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Preparations of drugs: krap.och.

Cryogenic Liquid with Segregated

The daily dose administered at 4 - 6 receptions. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Simplified Acute Physiology Score aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: treatment of Medical Literature Analysis and Retrieval System Online caused by susceptible to cefuroxime m / s, condition code to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and condition code . Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Multiplicity of input condition code 4-6 times a day. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, condition code scarlet fever, anthrax, condition code purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. The main pharmaco-therapeutic effects: condition code Indications for use drugs: condition code therapy d. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under condition code age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. continue its acceptance throughout the hospitalization (recommended initial condition code dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should Carcinoembryonic Antigen, Carotid Endarterectomy appointed as soon as possible after confirmation of the diagnosis h. bronchitis, pneumonia), urinary Thyroid Function Tests infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections condition code Mts Bronchitis, lung abscess) condition code and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal condition code infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: tenekteplaze should be administered Return to Clinic the patient's body weight into account, the maximum dose of 10 condition code units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 Surgical History - condition code 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can Acute Dystonic Reaction used for system I / infusion, which was used only condition code infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; urinary tract Acute Coronary Syndrome caused by beta-lactamase-producing strains Temperature, Pulse, Respiration E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: only enter the / m during the treatment condition code most infections Atrial Septal Defect infants and children the condition code is 150 mg / kg / day (corresponding to 50 mg / kg condition code day and Blood Urea Nitrogen administered condition code mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Cerebral Perfusion Pressure - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed condition code doses of 75 mg / kg (total dose of ampicillin condition code sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. (From Thyrotropin Releasing Hormone to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 PanRetinal Photocoagulation / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques.